Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;34(6):2159-2162.
doi: 10.1007/s40620-021-01099-7. Epub 2021 Jun 28.

Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

Tristan de Nattes  1   2 , Arnaud François  3 , Sophie Candon  4 , Isabelle Etienne  5 , Charlotte Laurent  5 , Marie Matignon  6   7 , Antoine Morel  6 , Johan Noble  8 , Martin Planchais  9 , Dominique Guerrot  5 , Dominique Bertrand  5
Affiliations

Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

Tristan de Nattes et al. J Nephrol. 2021 Dec.
No abstract available

Keywords: Belatacept; Chronic allograft nephropathy; Chronic-active Antibody Mediated Rejection; Immunosuppressive agent; Kidney transplant.

PubMed Disclaimer

References

    1. Le Meur Y, Aulagnon F, Bertrand D et al (2016) Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors. Am J Transpl 16:2181–2186. https://doi.org/10.1111/ajt.13698 - DOI
    1. Leibler C, Matignon M, Moktefi A et al (2019) Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR). Am J Transpl 19:894–906. https://doi.org/10.1111/ajt.15229 - DOI
    1. Kumar D, Raynaud M, Chang J et al (2020) Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection. Transplantation. https://doi.org/10.1097/TP.0000000000003278
    1. Senev A, Coemans M, Lerut E et al (2019) Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome. Am J Transpl 19:763–780. https://doi.org/10.1111/ajt.15074 - DOI
    1. Bertrand D, Cheddani L, Etienne I et al (2017) Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study. Am J Transpl 17:2937–2944. https://doi.org/10.1111/ajt.14427 - DOI

MeSH terms

LinkOut - more resources